ICON Free Cash Flow 2010-2024 | ICLR
ICON annual/quarterly free cash flow history and growth rate from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- ICON free cash flow for the quarter ending December 31, 2024 was 1,118.59, a year-over-year.
- ICON free cash flow for the twelve months ending December 31, 2024 was , a year-over-year.
- ICON annual free cash flow for 2024 was $1.119B, a 9.63% increase from 2023.
- ICON annual free cash flow for 2023 was $1.02B, a 142.27% increase from 2022.
- ICON annual free cash flow for 2022 was $0.421B, a 42.73% decline from 2021.
| ICON Annual Free Cash Flow | |
|---|---|
| 2024 | 1,118.59 |
| 2023 | 1,020.34 |
| 2022 | 421.16 |
| 2021 | 735.39 |
| 2020 | 527.15 |
| 2019 | 361.90 |
| 2018 | 220.24 |
| 2017 | 338.37 |
| 2016 | 216.60 |
| 2015 | 229.34 |
| 2014 | 136.26 |
| 2013 | 191.74 |
| 2012 | 82.64 |
| 2011 | -15.09 |
| 2010 | 56.47 |
| 2009 | 221.28 |
| ICON Quarterly Free Cash Flow | |
|---|---|
| 2024-12-31 | 1,118.59 |
| 2024-09-30 | 841.57 |
| 2024-06-30 | 482.23 |
| 2024-03-31 | 299.92 |
| 2023-12-31 | 1,020.34 |
| 2023-09-30 | 632.92 |
| 2023-06-30 | 320.50 |
| 2023-03-31 | 148.76 |
| 2022-12-31 | 421.16 |
| 2022-09-30 | 537.60 |
| 2022-06-30 | 361.13 |
| 2022-03-31 | 207.28 |
| 2021-12-31 | 735.39 |
| 2021-09-30 | 493.26 |
| 2021-06-30 | 218.70 |
| 2021-03-31 | 103.22 |
| 2020-12-31 | 527.15 |
| 2020-09-30 | 344.59 |
| 2020-06-30 | 239.49 |
| 2020-03-31 | 131.45 |
| 2019-12-31 | 361.90 |
| 2019-09-30 | 246.17 |
| 2019-06-30 | 99.15 |
| 2019-03-31 | 87.60 |
| 2018-12-31 | 220.24 |
| 2018-09-30 | 179.39 |
| 2018-06-30 | 62.45 |
| 2018-03-31 | 32.16 |
| 2017-12-31 | 338.37 |
| 2017-09-30 | 253.49 |
| 2017-06-30 | 153.24 |
| 2017-03-31 | 151.03 |
| 2016-12-31 | 216.60 |
| 2016-09-30 | 99.69 |
| 2016-06-30 | 57.32 |
| 2016-03-31 | 51.66 |
| 2015-12-31 | 229.34 |
| 2015-09-30 | 127.17 |
| 2015-06-30 | 65.10 |
| 2015-03-31 | 50.43 |
| 2014-12-31 | 137.17 |
| 2014-09-30 | 72.13 |
| 2014-06-30 | -29.21 |
| 2014-03-31 | 32.50 |
| 2013-12-31 | 191.74 |
| 2013-09-30 | 100.41 |
| 2013-06-30 | 63.01 |
| 2013-03-31 | 59.98 |
| 2012-12-31 | 82.64 |
| 2012-09-30 | 79.11 |
| 2012-06-30 | 56.38 |
| 2012-03-31 | 54.13 |
| 2011-12-31 | -15.09 |
| 2011-09-30 | -42.22 |
| 2011-06-30 | -24.74 |
| 2011-03-31 | -11.30 |
| 2010-12-31 | 56.47 |
| 2010-09-30 | 31.60 |
| 2010-06-30 | 34.86 |
| 2010-03-31 | 7.22 |
| 2009-12-31 | 221.28 |
| 2009-09-30 | 172.35 |
| 2009-06-30 | 111.68 |
| 2009-03-31 | 16.55 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.183B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.427B | 26.15 |
| Elevance Health (ELV) | United States | $93.171B | 12.02 |
| CVS Health (CVS) | United States | $85.832B | 10.67 |
| Cencora (COR) | United States | $55.028B | 19.14 |
| Natera (NTRA) | United States | $21.977B | 0.00 |
| DiDi Global (DIDIY) | China | $20.426B | 31.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.484B | 0.00 |
| Solventum (SOLV) | United States | $11.527B | 12.20 |
| CochLear (CHEOY) | Australia | $11.409B | 0.00 |
| Doximity (DOCS) | United States | $11.080B | 57.62 |
| Revvity (RVTY) | United States | $10.950B | 18.84 |
| Viatris (VTRS) | United States | $10.779B | 3.67 |
| Medpace Holdings (MEDP) | United States | $8.646B | 22.96 |
| Avantor (AVTR) | United States | $8.368B | 12.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.191B | 0.00 |
| HealthEquity (HQY) | United States | $7.900B | 38.86 |
| Charles River Laboratories (CRL) | United States | $6.943B | 13.60 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $4.064B | 23.96 |
| BrightSpring Health Services (BTSG) | United States | $3.924B | 36.32 |
| Sotera Health (SHC) | United States | $3.755B | 21.34 |
| Alignment Healthcare (ALHC) | United States | $3.051B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.907B | 33.35 |
| Concentras Parent (CON) | United States | $2.706B | 15.64 |
| Organon (OGN) | United States | $2.345B | 2.49 |
| Premier (PINC) | United States | $2.127B | 14.56 |
| Ardent Health Partners (ARDT) | United States | $2.078B | 8.88 |
| Progyny (PGNY) | United States | $2.002B | 44.09 |
| GoodRx Holdings (GDRX) | United States | $1.627B | 30.29 |
| PACS (PACS) | United States | $1.615B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.582B | 61.93 |
| Agilon Health (AGL) | United States | $1.333B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.242B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.240B | 9.44 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.004B | 0.00 | |
| CareDx (CDNA) | United States | $0.857B | 13.38 |
| AMN Healthcare Services Inc (AMN) | United States | $0.776B | 7.29 |
| Embecta (EMBC) | United States | $0.773B | 5.30 |
| QDM (QDMI) | Hong Kong, SAR China | $0.674B | 0.00 |
| Nutex Health (NUTX) | United States | $0.667B | 13.08 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.61 |
| Enhabit (EHAB) | United States | $0.491B | 40.38 |
| InnovAge Holding (INNV) | United States | $0.482B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.464B | 0.00 |
| LifeMD (LFMD) | United States | $0.371B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.349B | 0.00 |
| SBC Medicals (SBC) | United States | $0.336B | 0.00 |
| DocGo (DCGO) | United States | $0.238B | 38.83 |
| Oncology Institute (TOI) | United States | $0.221B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.176B | 0.00 |
| Beauty Health (SKIN) | United States | $0.155B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
| So-Young (SY) | China | $0.085B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.081B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.080B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.051B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| KindlyMD (KDLY) | United States | $0.023B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |